Registered dietitian Ayla Barmmer told The Post that about 15% of her patients taking GLP-1 medications have struggled to ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Dr Richard Viney, a consultant urological surgeon at the Queen Elizabeth Hospital in Birmingham, believes the spike in penis ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

New UK research reveals that combining weight loss injections with coaching and regular tracking can lead to 53% more ...

compared with about 16% of Wegovy users. In both groups, weight loss was about 6% lower in men than in women, AP said. Both groups saw health improvements in blood pressure, blood sugar and blood ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.

compared with just 16% of Wegovy users. In both groups, weight loss was about 6% lower in men than in women. These findings were presented at the European Congress on Obesity in Malaga ...

Male ozempic users shared their thoughts on Reddit on how the weight loss drug did not shrink but bulged another body part ...

For weight loss, people on Wegovy lost about 13.7% of their body ... finding was that women in both groups lost more weight than men. On average, men lost about 6% less. More than three-quarters ...

compared to about 16 per cent of those taking Wegovy, the study found. Weight loss was about six per cent lower in men than in women in both groups, the authors noted. As participants in both ...